Finding and characterizing mammary analogue secretory carcinoma of the salivary gland

Korean Journal of Pathology

Volumn 47, Issue 1, 2013, Pages 36-43

  Jung, Min Jung ^a   Song, Joon Seon ^a   Kim, Sang Yoon ^a   Nam, Soon Yuhl ^a   Roh, Jong Lyel ^a   Choi, Seung Ho ^a   Kim, Sung Bae ^a   Cho, Kyung Ja ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Carcinoma, acinar cell; ETV6 NTRK3 fusion protein, human; In situ hybridization, fluorescence; Salivary gland neoplasms

Indexed keywords

EID: 84874965228     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.1.36     Document Type: Article

References (10)

1. Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010; 34: 599-608.
2. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch 2011; 459: 117-8.
3. Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 2012; 36: 27-34.
4. Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol 2012; 36: 343-50.
5. Chiosea SI, Griffith C, Assaad A, Seethala RR. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology 2012; 61: 387-94.
6. Chi HT, Ly BT, Kano Y, Tojo A, Watanabe T, Sato Y. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun 2012; 429: 87-92.
7. Tognon CE, Somasiri AM, Evdokimova VE, et al. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res 2011; 71: 1060-70.
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
9. Skálová A, Sima R, Vanecek T, et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol 2009; 33: 1137-45.
10. Chenevert J, Duvvuri U, Chiosea S, et al. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 2012; 25: 919-29.